Skip to Content

Join the 'Cerebral Spasticity' group to help and get support from people like you.

Cerebral Spasticity News

FDA Approves Movement Disorder Drug from CNS Therapeutics: Gablofen (Baclofen Injection) for the Treatment of Severe Spasticity

Posted 23 Nov 2010 by Drugs.com

ST. PAUL, Minn.--(BUSINESS WIRE)--Nov 23, 2010 - Today, CNS Therapeutics announced the FDA approval of Gablofen (baclofen injection) for use in the management of severe spasticity, giving healthcare providers a new, easy-to-administer and cost-effective intrathecal baclofen treatment option. Severe spasticity is a movement disorder affecting more than 500,000 patients in the U.S. alone and is ...

Ask a Question

Further Information

Related Condition Support Groups

Cerebral Palsy, Central Nervous System Disorders

Related Drug Support Groups

baclofen, Artane, trihexyphenidyl, Lioresal, Lioresal Intrathecal, Gablofen, Trihexane, Kemstro, Trihexy